argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx is translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx’s first experimental medicine, efgartigimod, is being evaluated in multiple autoimmune diseases, including myasthenia gravis (MG), pemphigus vulgaris (PV), immune thrombocytopenia (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP).
argenx is located in Ghent, Belgium, Boston, Massachusetts and Tokyo, Japan.
Location: Belgium, East Flanders, Zwijnaarde
Employees: 501-1000
Founded date: 2008
Investors 1
| Date | Name | Website |
| - | Avoro Capi... | avorocapit... |
Mentions in press and media 13
| Date | Title | Description | Source |
| 07.03.2024 | argenx Delivers on Promise to Transform Patient Expectations... | - | globenewsw... |
| 17.04.2023 | argenx and Genmab Enter Partnership to Advance Antibody Ther... | Genmab and argenx have entered into a multiyear collaboration bringing together capabilities to join... | aithority.... |
| 16.01.2023 | argenx Announces Extraordinary General Meeting of Shareholde... | January 16, 2023 Amsterdam, the Netherlands – argenx SE ((Euronext &, NASDAQ:ARGX), a global imm... | einpresswi... |
| 06.06.2022 | Medison Pharma Announces Multi-Regional Partnership Agreemen... | PETACH TIKVAH, Israel, June 6, 2022 /PRNewswire/ -- Medison Pharma ("Medison"), a global p... | en.prnasia... |
| 05.05.2022 | Argenx Stock Climbs as Sales of New Drug Blow Past Expectati... | Sales of argenx new, potential blockbuster Vyvgart are off to a very strong start, coming in many ti... | barrons.co... |
| 19.12.2021 | FDA approval of Argenx neuromuscular disease therapy is firs... | An Argenx drug developed to treat the rare neuromuscular disorder generalized myasthenia gravis is n... | medcitynew... |
| 17.06.2021 | ARGENX SE Argenx's drug effective against muscle-weakening ... | June 16 (Reuters) - An experimental drug developed by argenx SE led to improvements in daily activit... | marketscre... |
| 28.05.2021 | BB Biotech : investment trust review highlights long t... | Launched in 1993, BB Biotech (BION) is one of the largest specialist funds investing in the fast-gro... | marketscre... |
| 26.05.2020 | Pivotal myasthenia gravis data from argenx augur well ... | Leading the pack of biotechs vying for a piece of the generalized myasthenia gravis (gMG) mar... | endpts.com... |
| 12.03.2020 | Precision biologics: the key to reducing antibiotic use in l... | Pathogens, as is clear to anyone tracking the outbreak of Covid-19 on humans or African Swine Fever ... | agfunderne... |
Show more